A System on the Brink


The 2026-2027 Petpocalypse is coming


Tens of millions of new pets acquired worldwide in the first year of Covid. The largest surge in recorded history

10% of vet clinics were corporate-owned in 2015; today, >60%. Costs increased by 63%, owners unable to afford care 264%*

There is a global shortage of vets; particularly specialists (∼500 cardiologists worldwide)

Around 40-50% of pets develop chronic conditions by age 6-7

2026-2027: the Covid cohort turns 6-7
Tens of millions will enter chronic disease
The veterinary system fractures


* UK, mirroring global pattern. 264% increase measured by Blue Cross emergency applications.

** Our founder's father lived 39 years with an undiagnosed cardiac condition that would have been fatal — passing every check-up because no one listened to his heart for longer than 30 seconds. Sonus exists so others don't have to

Sonus Health is the clinical infrastructure layer for a capacity-constrained veterinary system


One specialist. Many clinics. Every pet. In 30 seconds.

Sonus turns specialist care from scarce labour into scalable clinical infrastructure. Enabling vets and nurses to deliver specialist-guided assessments in-clinic and at-home

Vets, nurses, or owners hold a smartphone against the animal. End-to-end proprietary audio AI extracts hospital-grade physiological data in 30 seconds

The platform creates a unified pet health record. Specialists require only minutes to sign off on the final report. Sonus then automatically follows up with owners, increasing conversion


Sonus increases clinic revenue and improves patient outcomes – without increasing headcount

Operational in CVS Group clinics

Instant preliminary results

Powering the modern veterinary operating model


500 cardiologists worldwide. Sonus turns each into many.

Accelerate the shift to roaming (peripatetic) specialist models corporates are actively pursuing by enabling scarce, high-cost specialists to cover many clinics

Support the shift to nurse-led clinics, triage and escalation by giving nurses specialist-guided assessment capabilities

Increase follow-up conversion and clinic revenue through automated reports, reminders and owner communication

Open new recurring revenue streams via remote and longitudinal monitoring at home, improving patient outcomes


Sonus powers the strategy large vet groups are already pursuing: specialist leverage, nurse activation, cost-effective care

Explosive Growth & Momentum


Pre-Launch - validation (Jun 2025)

Pre-launch we surveyed a network of 400 veterinary cardiologists and GPs – the Veterinary Cardio Club, with whom we are now partnered – focusing on 12 key clinics

91.6%

Purchase Intent

91.6% of surveyed clinics said they and their clients would pay for Sonus immediately

Launch (Feb 10-16 2026)

125+

clinics signed up within days to the waitlist, from across 6 continents *

3.1

new clinics per business hour during launch window


3.5 months since launch (June 2026)

277

clinics worldwide using Sonus
(incl. 82 from waitlist & early access)

3,132

Sonus scans performed on patients

984

animals' medical data being managed on our platform

1,004

cardiac murmurs detected by our heart scans

188

board-certified cardiologist reports delivered to clinics

2.6

new clinics / business day sustained average

$0 spent on marketing


* from across India, Greece, Singapore, Spain, Ireland, UAE, Kuwait, New Zealand, Belgium, Iran, Czech Republic, Poland, Columbia, Jordan, Egypt, Mexico, Norway, Germany, Brasil, Venezuela, Lithuania, Italy, Switzerland, UK, Taiwan, Romania, Hungary, Canada, USA, Bangladesh, Vietnam, Malaysia, Serbia, Pakistan, Cyprus, Estonia, Netherlands, Australia, Finland and Honduras

** Clinics range from small practices to large hospitals such as the National Veterinary Hospital in Taiwan, Greencross Animal Hospital in Australia, Evidensia Animal Hospital in Netherlands, Tata Small Animal Hospital Mumbai, The Veterinary Hospital of the UAE, The Royal Zoological Society of Scotland etc.

Ongoing Enterprise Pilot: CVS Group

Our first enterprise-scale pilot is underway with CVS Group, one of Europe's largest veterinary service providers, with 500 practices across the UK and Australia, supporting its move towards nurse-led clinics in 2026


CVS Group Numbers

Sonus' reports correlated perfectly with my findings - a great tool for between checks, for me to monitor my patients as diseases progress, and for our nurses to use when they suspect a murmur or arrhythmia
Dr Rosie Barker, Cardiology Committee Chair, CVS Veterinary Group


Pilot Structure

Launch

Kicked off on Jan 5th 2026 across three CVS clinics

Orientation

14 weeks of onboarding and workflow embedding

Operation

5 weeks of operating identical to final commercial structure

Commercial Transition

Move to retail pricing, with discounted enterprise tiers

Now completed, in active commercial transition negotiations at week 21


Pricing

At CVS, nurses estimate around 20 reports per week per clinic

$34.99

per report

$3,040

month / clinic

$36,489

year / clinic

delivering ~43% margins for CVS, with rollout potential across 500 clinics

How clinics deploy and monetise Sonus


A clinic or group subscribes, unlocking scanning, reporting and monitoring tools on flexible credit-based plans

Clinics invite the owner, upload the health record and set up a paid care plan for the animal, charging the client directly at a 30–50% margin

Vets or owners scan at home or in-clinic, yielding instant HR, HRV and murmur results that also appear on the clinic internal dashboard

A board-certified specialist cardiologist report is delivered within 24 hours and automatically integrated into the patient's health record

Report findings trigger owner explainers, reminders, clinic follow-up and repeat scans, driving ongoing care and follow-up revenue


Sonus gives clinics a scalable platform for cardiac screening, reporting and follow-up – increasing access to specialist care while creating a monetisable workflow


Leadership


Dr Roeland Decorte

CEO & founder

  • Built Sonus' core technology, endorsed by UK MoD and gov, raised ~$2M as solo founder
  • BA/MA, MPhil, PhD Cambridge; youngest Belgian ever to matriculate

Daniel Steele

CTO

  • Co-founder & CTO, then CEO, at eola.co, one of Europe's largest booking platforms
  • Built and scaled the full stack from $0 to $67M in booking revenue

Prof Laurent Locquet

Head Vet

  • One of just ~500 board-certified veterinary cardiologists worldwide; Certified Perfusionist
  • Founder of Vet Cardio Club, with 433 paying veterinary clinicians


3x founding, 0→1 and scaling experience

Built tech endorsed
by the UK Ministry of Defence

Founded one of Europe's largest booking platforms

Founded the world's largest veterinary cardiology community

End-to-end proprietary

Automatic auscultation automates the process of a doctor analysing body sounds using a stethoscope. In our case, without the doctor or the stethoscope – only a smartphone


Sonus combines end-to-end proprietary Digital Signal Processing and Machine Learning, built on 5+ years of fully in-house data and R&D


To our knowledge, we are the only company in the world that has achieved automatic auscultation using smartphones


Partnerships


Petgevity

Industry: Pet insurance

Location: United Kingdom

Size: 400K insured pets

First contact: Inbound

Stage: Marketing collab agreed

Santévet

Industry: Pet insurance

Location: France

Size: 600K insured pets

First contact: Outbound

Stage: Marketing collab agreed

Vetoquinol

Industry: Pharmaceutical

Location: France

Size: €939.9 million (listed)

First contact: Outbound

Stage: Validation stage

Paws on Plates

Industry: Pet food

Location: United Kingdom

Size: 10M+ meals delivered

First contact: Inbound

Stage: outreach 20K clients 10/6/26

Smartemis

Industry: Vet Group

Location: Germany & France

Size: 130 clinics

First contact: Inbound

Stage: Pilot scoping

Meikovet Group

Industry: Vet Group

Location: Switzerland

Size: 13 clinics

First contact: Outbound

Stage: Pilot validation stage

Vet Candy / Pet Candy

Industry: Vet Continuing Education / News

Location: United States

Size: 50K veterinarians

First contact: Inbound

Stage: Initial structure agreed

Pet insurers are natural partners

  • offer differentiated, personalised services to clients
  • reduce claims through earlier detection, fast response
  • measure compliance and progression at home

Pharma companies are natural partners

  • support dose adjustment
  • track treatment response and compliance
  • improve effectiveness while reducing adverse events


Appendix A: Health metrics captured


Sonus captures everything a cardiologist can measure during auscultation in-clinic

Anywhere, anytime – even if the patient is asleep at home


Immediate preliminary results

Instant top-level results after each scan, including heart rate (HR), heart rate variability (HRV) and murmur indications (e.g. MMVD)

Report request for full results

The clinic then buys a specialist report reviewed by a board-certified cardiologist, who evaluates the AI output and recording via a custom dashboard. The report assesses all health metrics listed below

Report delivery in 24 hours

The report is delivered on-platform, taking into account all current and historical patient context (age, weight, clinical background, breed, meds) in its assessment of murmurs, arrhythmias, therapy response, disease progression


Full list of metrics and conditions captured

Core cardiac metrics

  • Heart rate (resting, exertional, situational)
  • Heart rate variability (HRV) and autonomic balance
  • Beat-to-beat variability patterns
  • Persistent bradycardia or tachycardia
  • Rate control adequacy over time

Heart rhythm & electrical stability

  • Normal sinus rhythm
  • Respiratory sinus arrhythmia (benign vs pathological)
  • Premature beats / ectopy (isolated or recurrent)
  • Atrial fibrillation (presence, rate control)
  • Sinus node dysfunction indicators (pauses, bradycardic trends)
  • Irregularly irregular rhythms
  • Changes in rhythm over time (longitudinal trend detection)

Heart sounds & structural indicators

  • Presence or absence of heart murmurs
  • Murmur intensity and progression
  • Timing of murmurs (e.g. systolic, post-S1)
  • Early signs of valvular disease (e.g. MMVD)
  • Murmur changes suggesting chamber dilation or disease progression
  • Differentiation of cardiac vs non-cardiac sounds

Disease detection & progression

  • Myxomatous mitral valve disease (early detection → progression)
  • Hypertrophic cardiomyopathy indicators
  • Dilated cardiomyopathy–associated changes
  • Advanced heart disease stability vs deterioration
  • Progression risk signals (e.g. falling HRV, rising resting HR)
  • Longitudinal disease trajectories rather than single snapshots

Therapy monitoring & response

  • Antiarrhythmic therapy effectiveness
  • Rate-control adequacy in atrial fibrillation
  • Atenolol and beta-blocker response
  • Detection of worsening after medication changes
  • Post-operative cardiac recovery
  • Stability on chronic cardiac medication regimens

Event-based and situational monitoring

  • Syncope / fainting episodes
  • Collapse during or after exertion
  • Intermittent events not reproducible in clinic
  • Physiological changes during real-world episodes
  • Situations where ECGs or Holters fail

Risk reduction & clinical workflow

  • Post-discharge deterioration
  • Unexpected progression between visits
  • Anaesthetic risk clearance support
  • Reassurance in normal or benign cases
  • Identification of when escalation or referral is truly needed

Appendix B: Lives saved

60+

Cat and dog lives saved in three months, by identifying life-threatening conditions that may otherwise have gone undetected


Shasha (pictured)

"This cat has been losing consciousness. Two 24 hours Holters missed every episode. Around forty Kardia ECGs were reviewed, but every faint produced indecipherable data."

Shasha, a 3-year-old Persian cat was repeatedly losing consciousness at home. Emergency, specialist and cardiology work-up, including repeated ECGs in-clinic, and Holter and Kardia monitoring at-home, failed to identify the cause

Shasha was put on meds for her heart, but deteriorated dramatically within 48h. With loss of consciousness continuing, her team reached out to Sonus to capture her heart during fainting episodes

Within two reports, we determined Shasha’s heart rhythm was stable during episodes but rather identified respiratory sounds indicating the issue was an upper-airway obstruction, not the heart. This had been missed as Shasha was routinely given a calming drug for clinic visits, masking her breathing issues that owners had mistaken for purring

Sonus reframed the case, redirected care, and avoided escalating the wrong diagnostic path — preventing a fatal outcome

Made with